Increased in Vitro Migration of Human Umbilical Cord Mesenchymal Stem Cells Toward Acellular Foreskin Treated with Bacterial Derivatives of Monophosphoryl Lipid A or Supernatant of Lactobacillus Acidophilus

Overview

Journal Hum Cell

Publisher Springer

Specialty Cell Biology

Date 2019 Dec 8

PMID 31811569

Citations 3

Authors

Ali Shojaeian

Ameneh Mehri-Ghahfarrokhi

Mehdi Banitalebi-Dehkordi

Affiliations

Soon will be listed here.

Abstract

Migration and homing are known as critical steps toward regeneration of damaged tissues via cell therapies. Among various cellular sources of stem cells, the umbilical cord has been thus recognized as an interesting one endowed with high benefits. Accordingly, the main objective of the present study was to determine whether monophosphoryl lipid A (MPLA) or supernatant of Lactobacillus acidophilus (SLA) could increase migration of human umbilical cord mesenchymal stem cells (hUMSCs) toward acellular foreskin or not. In this study, the hUMSCs were isolated and cultured through acellular MPLA- or SLA-treated foreskin. Expression of some migration genes (i.e., VCAM-1, MMP-2, VLA-4, CXCR-4, and VEGF) was also investigated using quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR). Moreover; vimentin, cytokeratin 5 (CK5), and matrix metalloproteinases-2 (MMP-2) were detected via immunohistochemistry (IHC) analysis. The hUMSCs in the presence of MPLA- or SLA-treated foreskin showed more tissue tropism compared with those in the control group. Besides, the scanning electron microscopy (SEM) results established that the hUMSCs had more migratory activity in the presence of MPLA- or SLA-treated foreskin than the untreated one. The IHC analysis results correspondingly indicated that expression of vimentin, CK5, and MMP-2 proteins had augmented in both treatments compared with those in the control group. It was concluded that MPLA had revealed more prominent results than SLA, even though both treatments could be regarded as inducing factors in migration. Ultimately, it was suggested to introduce the use of MPLA and probiotic components as a promising approach to improve therapies in regenerative medicine.

Citing Articles

Opportunities and challenges of bacterial extracellular vesicles in regenerative medicine.

Guo J, Huang Z, Wang Q, Wang M, Ming Y, Chen W J Nanobiotechnology. 2025; 23(1):4.

PMID: 39754127 PMC: 11697683. DOI: 10.1186/s12951-024-02935-1.

The Therapeutic Potential of Human Umbilical Cord Mesenchymal Stromal Cells Derived Exosomes for Wound Healing: Harnessing Exosomes as a Cell-free Therapy.

Dehghani L, Owliaee I, Sadeghian F, Shojaeian A J Stem Cells Regen Med. 2024; 20(1):14-23.

PMID: 39044811 PMC: 11262847. DOI: 10.46582/jsrm.2003003.

Monophosphoryl Lipid A and Retinoic Acid Combinations Increased Germ Cell Differentiation Markers Expression in Human Umbilical Cord-derived Mesenchymal Stromal Cells in an Ovine Acellular Testis Scaffold.

Shojaeian A, Mehri-Ghahfarrokhi A, Banitalebi-Dehkordi M Int J Mol Cell Med. 2021; 9(4):288-296.

PMID: 33688486 PMC: 7936076. DOI: 10.22088/IJMCM.BUMS.9.4.288.

References

Erices A, Conget P, Minguell J . Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000; 109(1):235-42. DOI: 10.1046/j.1365-2141.2000.01986.x. View

Purcell B, Elser J, Mu A, Margulies K, Burdick J . Synergistic effects of SDF-1α chemokine and hyaluronic acid release from degradable hydrogels on directing bone marrow derived cell homing to the myocardium. Biomaterials. 2012; 33(31):7849-57. PMC: 3449064. DOI: 10.1016/j.biomaterials.2012.07.005. View

Cheng Z, Ou L, Zhou X, Li F, Jia X, Zhang Y . Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther. 2008; 16(3):571-9. DOI: 10.1038/sj.mt.6300374. View

Chavez-Munoz C, Nguyen K, Xu W, Hong S, Mustoe T, Galiano R . Transdifferentiation of adipose-derived stem cells into keratinocyte-like cells: engineering a stratified epidermis. PLoS One. 2013; 8(12):e80587. PMC: 3846628. DOI: 10.1371/journal.pone.0080587. View

Ruster B, Gottig S, Ludwig R, Bistrian R, Muller S, Seifried E . Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood. 2006; 108(12):3938-44. DOI: 10.1182/blood-2006-05-025098. View

Ivaska J, Pallari H, Nevo J, Eriksson J . Novel functions of vimentin in cell adhesion, migration, and signaling. Exp Cell Res. 2007; 313(10):2050-62. DOI: 10.1016/j.yexcr.2007.03.040. View

Ganguli K, Walker W . Probiotics in the prevention of necrotizing enterocolitis. J Clin Gastroenterol. 2011; 45 Suppl:S133-8. DOI: 10.1097/MCG.0b013e318228b799. View

Romero C, Varma T, Hobbs J, Reyes A, Driver B, Sherwood E . The Toll-like receptor 4 agonist monophosphoryl lipid a augments innate host resistance to systemic bacterial infection. Infect Immun. 2011; 79(9):3576-87. PMC: 3165493. DOI: 10.1128/IAI.00022-11. View

Yun S, Shin T, Lee J, Cho M, Kim I, Kim J . Design of Magnetically Labeled Cells (Mag-Cells) for in Vivo Control of Stem Cell Migration and Differentiation. Nano Lett. 2018; 18(2):838-845. DOI: 10.1021/acs.nanolett.7b04089. View

10.

Secunda R, Vennila R, Mohanashankar A, Rajasundari M, Jeswanth S, Surendran R . Isolation, expansion and characterisation of mesenchymal stem cells from human bone marrow, adipose tissue, umbilical cord blood and matrix: a comparative study. Cytotechnology. 2014; 67(5):793-807. PMC: 4545441. DOI: 10.1007/s10616-014-9718-z. View

11.

Chen M, Lin C, Chiu Y, Chen C, Tsai P, Wang H . IL-1-Induced Matrix Metalloprotease-1 Promotes Mesenchymal Stem Cell Migration via PAR1 and G-Protein-Coupled Signaling Pathway. Stem Cells Int. 2018; 2018:3524759. PMC: 6031215. DOI: 10.1155/2018/3524759. View

12.

Ravi M, Paramesh V, Kaviya S, Anuradha E, Paul Solomon F . 3D cell culture systems: advantages and applications. J Cell Physiol. 2014; 230(1):16-26. DOI: 10.1002/jcp.24683. View

13.

Son B, Marquez-Curtis L, Kucia M, Wysoczynski M, Turner A, Ratajczak J . Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells. 2006; 24(5):1254-64. DOI: 10.1634/stemcells.2005-0271. View

14.

Janowska-Wieczorek A, Marquez L, Dobrowsky A, Ratajczak M, Cabuhat M . Differential MMP and TIMP production by human marrow and peripheral blood CD34(+) cells in response to chemokines. Exp Hematol. 2000; 28(11):1274-85. DOI: 10.1016/s0301-472x(00)00532-4. View

15.

Murphy C, Matsiko A, Haugh M, Gleeson J, OBrien F . Mesenchymal stem cell fate is regulated by the composition and mechanical properties of collagen-glycosaminoglycan scaffolds. J Mech Behav Biomed Mater. 2012; 11:53-62. DOI: 10.1016/j.jmbbm.2011.11.009. View

16.

Li Y, Yu X, Lin S, Li X, Zhang S, Song Y . Insulin-like growth factor 1 enhances the migratory capacity of mesenchymal stem cells. Biochem Biophys Res Commun. 2007; 356(3):780-4. DOI: 10.1016/j.bbrc.2007.03.049. View

17.

Halper J, Leshin L, Lewis S, Li W . Wound healing and angiogenic properties of supernatants from Lactobacillus cultures. Exp Biol Med (Maywood). 2003; 228(11):1329-37. DOI: 10.1177/153537020322801111. View

18.

Augello A, Kurth T, De Bari C . Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches. Eur Cell Mater. 2011; 20:121-33. DOI: 10.22203/ecm.v020a11. View

19.

Andreas K, Sittinger M, Ringe J . Toward in situ tissue engineering: chemokine-guided stem cell recruitment. Trends Biotechnol. 2014; 32(9):483-92. DOI: 10.1016/j.tibtech.2014.06.008. View

20.

Kang S, Shin I, Ko M, Jo J, Ra J . Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapy. Stem Cells Int. 2012; 2012:342968. PMC: 3382267. DOI: 10.1155/2012/342968. View